Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Us...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo
Format:	Artigo
Jezik:	Inglês
Izdano:	Oxford University Press 2025-10-01
Serija:	ESC Heart Failure
Teme:	Heart failure, systolic Hospitalization Kidney failure, chronic Mortality Renin‐angiotensin system Treatment outcome
Online dostop:	https://doi.org/10.1002/ehf2.15359
Oznake:	Označite Brez oznak, prvi označite!